Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14519376 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL3819958 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL14519375 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL1639746 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Fluoride SCHEMBL11231130 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Hydrochloric Acid SCHEMBL2869749 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Water SCHEMBL29083027 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Ammonia Solution, Strong SCHEMBL16338366 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL895491 | 0.97 | — | — | |
| SCHEMBL2076710 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023173026-A1 | ANTIBODY-DRUG CONJUGATES AND USES THEREOF | SORRENTO THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| EP-1957073-A2 | MEDICINAL DRUG | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007066784-A2 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | WO | disclosed |
| EP-1773797-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014012-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |